Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Fulcrum Therapeutics (FULC) Return on Capital Employed (2019 - 2026)

Fulcrum Therapeutics (FULC) has disclosed Return on Capital Employed for 7 consecutive years, with 0.31% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed fell 22.0% to 0.31% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.31% through Dec 2025, down 22.0% year-over-year, with the annual reading at 0.28% for FY2025, 19.0% down from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.31% at Fulcrum Therapeutics, up from 0.39% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.05% in Q1 2025, with the low at 0.59% in Q2 2021.
  • Average Return on Capital Employed over 5 years is 0.38%, with a median of 0.41% recorded in 2021.
  • Peak annual rise in Return on Capital Employed hit 43bps in 2025, while the deepest fall reached -28bps in 2025.
  • Over 5 years, Return on Capital Employed stood at 0.36% in 2021, then plummeted by -42bps to 0.51% in 2022, then grew by 15bps to 0.43% in 2023, then soared by 81bps to 0.08% in 2024, then plummeted by -261bps to 0.31% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.31%, 0.39%, and 0.37% for Q4 2025, Q3 2025, and Q2 2025 respectively.